ARCHIVES

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

This article is from The Cancer Letter archive.

Vol. 40 No. 45 | December 5, 2014

Download PDF Visit The Full Archive

Related Articles

Cell Therapeutics To Appeal FDA Decision on Pixantrone.

September 17, 2010

DCBDC Board Ok’s New Initiative For Training

November 16, 1990

Haller Named Editor-In-Chief Of JCO; White House Appoints Duffy To NCAB.

March 17, 2000

Costs of Rosenberg Regimen Could Hinder cooperative Group Trials

January 3, 1986

More Women Over 50 Report Having Had Mammograms.

July 28, 2000

NCI-Approved Clinical Trials

November 24, 2006